Epilepsy
Full Extract Cannabis Oil (FECO) is one of the most studied and utilized natural interventions for Epilepsy, particularly for drug-resistant (refractory) cases. Unlike purified CBD isolates (like Epidiolex), FECO provides a "whole-plant" profile that many clinicians believe offers a superior therapeutic window due to the synergistic interaction of multiple cannabinoids.
1. Mechanisms: How FECO Stabilizes the Brain
Epileptic seizures are caused by "electrical storms" in the brain—an imbalance where excitatory signals overwhelm inhibitory ones. FECO restores balance through several pathways:
LPI/GPR55 Blockade: Research updated in 2025/2026 confirms that CBD in FECO blocks a molecule called LPI from binding to the GPR55 receptor. This prevents a "vicious cycle" where seizures trigger more LPI, which in turn triggers more seizures.
TRPV1 Desensitization: Cannabinoids act on vanilloid receptors, which regulate calcium flow in neurons. By desensitizing these, FECO lowers the likelihood of the rapid-fire neuronal firing that characterizes a seizure.
The "Entourage" Advantage: While CBD is the heavy lifter, minor cannabinoids in FECO (like THCV and CBDV) have shown independent anticonvulsant properties. Furthermore, small, non-psychoactive amounts of THCA (the raw form of THC) can act as a potent anti-inflammatory for the brain.
2. Clinical Benefits: FECO vs. Purified CBD
Meta-analyses in 2025 have provided compelling evidence for the "Whole Plant" approach:
| Feature | Purified CBD (Isolate) | FECO (Full Extract) |
|---|---|---|
| Seizure Reduction | ~46% of patients see improvement. | ~71% of patients see improvement. |
| Average Dose Needed | Higher (Avg. 25.3 mg/kg/day) | Lower (Avg. 6.0 mg/kg/day) |
| Side Effects | More frequent (Sedation, Diarrhea). | Fewer reported due to lower required doses. |
| Responders (≥50% reduction) | ~42% of patients. | ~39% of patients. |
Note: While purified CBD has a slightly higher "responder" rate for total seizure freedom in specific syndromes, FECO is often better tolerated and requires significantly less oil to achieve a baseline of relief.
3. Management of Specific Syndromes
FECO is especially beneficial for severe, pediatric-onset epilepsies where traditional meds often fail:
Dravet Syndrome: High-CBD FECO helps reduce the frequency of prolonged, heat-sensitive seizures.
Lennox-Gastaut Syndrome (LGS): Particularly effective for "drop seizures" (atonic seizures), helping to reduce injury risk.
Tuberous Sclerosis Complex (TSC): Helps manage the focal seizures associated with brain lesions.
4. Safety and 2026 Guidelines
Start Low, Go Slow: Clinical protocols in 2026 recommend starting at 2.5 mg/kg/day (total cannabinoids) and increasing weekly. In adults, this often starts at a dose the size of a grain of sand twice daily.
Dietary Fat: FECO is highly lipophilic (fat-soluble). Taking it with a high-fat meal (like avocado or yogurt) can increase absorption by up to 14 times.
Important: Never abruptly stop taking traditional anti-seizure medications when starting FECO. Abruptly stopping can trigger Status Epilepticus, a life-threatening, continuous seizure.